News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Genes & Cancer | CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

Genes & Cancer

February 10, 2023
PRESS RELEASE: A new review was published in Genes & Cancer on February 1, 2023, entitled, “CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.” continue reading »

Oncotarget | Everolimus Inhibits Angiogenesis and Lymphangiogenesis in TP53 Mutant HNSCC by Downregulating STAT3/HIF-1α/VEGF Pathway

News

February 9, 2023
PRESS RELEASE: On February 2, 2023, a new research paper was published in Oncotarget, entitled, “Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC).” continue reading »

Aging | Body Weight Influences Musculoskeletal Adaptation to Running in Aging Mice

Aging

February 8, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 2, entitled, “Body weight influences musculoskeletal adaptation to long-term voluntary wheel running during aging in female mice.” continue reading »

Oncotarget | The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

News

February 7, 2023
PRESS RELEASE: On February 4, 2023, Oncotarget published a new research perspective, entitled, “The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy.” continue reading »

Genes & Cancer | Leveraging Allogeneic Dendritic Cells for Neoantigen Cancer Vaccines

News

February 3, 2023
PRESS RELEASE: On January 30, 2023, a new research perspective was published in Genes & Cancer, entitled, “Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.” continue reading »